Seattle Genetics (SGEN)

$49.68 $0.11 (0.22%)

  • Last Price:
    $49.68
  • Previous Close:
    $49.57
  • Change:
    $0.11 (0.22%)
  • Open:
    $49.44
  • Volume:
    1,119,036
  • Day's Range:
    $48.97 - $49.86
  • Dividend Yield:
    0%
  • 52-week Range:
    $71.32 - $45.31
  • P-E:
    0
  • EPS:
    $-0.89

Seattle Genetics Inc is a biotechnology company. The company is focused on development and commercialization of targeted therapies for the treatment of cancer. Its products are ADCETRIS (brentuximab vedotin) US and ADCETRIS (brentuximab vedotin) Canada.